Bio-Thera Solutions (688177.SS) Stock Price

Bio-Thera Solutions Price

CLOSED
18.10CNY+0.33 (+1.84 %)
Market closed

Over the last 8 years Bio-Thera Solutions grew revenue by 100.9% annually, reaching 743.17 M CNY. For Bio-Thera Solutions, the net margin of -68.7% is up versus -277.4% a few years ago. The consensus 12-month price target for Bio-Thera Solutions is 36.92 CNY, about 104.0% above where the stock trades today. Of 5 analysts, 4 rate the stock a buy — an overall Buy consensus. The stock trades about 12% above its 52-week low.

Bio-Thera Solutions stock price

Volume
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Bio-Thera Solutions over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Bio-Thera Solutions stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Bio-Thera Solutions's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Bio-Thera Solutions Stock Price History
DateBio-Thera Solutions Price
8/5/202618.10 CNY
8/4/202617.77 CNY
8/3/202617.43 CNY
7/31/202617.11 CNY
7/30/202616.97 CNY
7/29/202617.09 CNY
7/28/202616.92 CNY
7/27/202617.13 CNY
7/24/202616.58 CNY
7/23/202616.94 CNY
7/22/202617.39 CNY
7/21/202617.42 CNY
7/20/202618.02 CNY
7/17/202618.18 CNY
7/16/202619.12 CNY
7/15/202619.35 CNY
7/14/202618.43 CNY
7/13/202618.08 CNY
7/10/202618.65 CNY
7/9/202617.80 CNY
7/8/202617.62 CNY
7/7/202617.94 CNY
7/6/202618.79 CNY
7/3/202618.69 CNY
7/2/202617.79 CNY
7/1/202617.99 CNY
6/30/202616.82 CNY
6/29/202617.36 CNY
6/26/202616.10 CNY
6/25/202616.78 CNY
6/24/202617.12 CNY
6/23/202617.16 CNY
6/22/202616.35 CNY
6/18/202617.18 CNY
6/17/202616.37 CNY
6/16/202616.89 CNY
6/15/202616.92 CNY
6/12/202617.34 CNY
6/11/202616.71 CNY
6/10/202616.85 CNY
6/9/202616.65 CNY
6/8/202616.90 CNY
6/5/202617.23 CNY
6/4/202617.47 CNY
6/3/202617.91 CNY
6/2/202618.39 CNY
6/1/202619.16 CNY
5/29/202619.01 CNY
5/28/202619.03 CNY
5/27/202619.02 CNY
5/26/202619.40 CNY
5/25/202619.75 CNY
5/22/202620.13 CNY
5/21/202620.09 CNY
5/20/202619.59 CNY
5/19/202619.80 CNY
5/18/202619.46 CNY
5/15/202619.58 CNY
5/14/202619.67 CNY
5/13/202620.05 CNY
5/12/202620.21 CNY
5/11/202620.35 CNY
5/8/202620.04 CNY
5/7/202620.40 CNY
5/6/202620.23 CNY
4/30/202620.60 CNY
4/29/202620.69 CNY
4/28/202621.20 CNY
4/27/202622.44 CNY
4/24/202622.22 CNY
4/23/202622.27 CNY
4/22/202622.60 CNY
4/21/202622.40 CNY
4/20/202622.64 CNY
4/17/202623.03 CNY
4/16/202623.45 CNY
4/15/202623.37 CNY
4/14/202624.90 CNY
4/13/202623.53 CNY
4/10/202623.07 CNY
4/9/202622.60 CNY
4/8/202623.17 CNY
4/7/202622.67 CNY
4/3/202622.56 CNY
4/2/202623.21 CNY
4/1/202623.09 CNY
3/31/202621.71 CNY
3/30/202621.75 CNY
3/27/202622.29 CNY
3/26/202620.50 CNY
3/25/202621.29 CNY
3/24/202621.43 CNY
3/23/202620.55 CNY
3/20/202622.08 CNY
3/19/202622.65 CNY
3/18/202623.12 CNY
3/17/202622.65 CNY
3/16/202622.53 CNY
3/13/202622.27 CNY
3/12/202622.56 CNY
3/11/202622.83 CNY
3/10/202623.17 CNY
3/9/202622.44 CNY
3/6/202622.62 CNY
3/5/202621.50 CNY
3/4/202621.29 CNY
3/3/202621.31 CNY
3/2/202622.21 CNY
2/27/202623.14 CNY
2/26/202623.24 CNY
2/25/202623.66 CNY
2/24/202623.54 CNY
2/13/202623.70 CNY
2/12/202623.86 CNY
2/11/202624.25 CNY
2/10/202624.26 CNY
2/9/202624.03 CNY
2/6/202623.68 CNY
2/5/202623.74 CNY
2/4/202623.61 CNY
2/3/202623.44 CNY
2/2/202622.85 CNY
1/30/202623.46 CNY
1/29/202623.75 CNY
1/28/202623.82 CNY
1/27/202624.80 CNY
1/26/202624.92 CNY
1/23/202624.92 CNY
1/22/202624.38 CNY
1/21/202624.26 CNY
1/20/202624.45 CNY
1/19/202624.80 CNY
1/16/202625.07 CNY
1/15/202625.18 CNY
1/14/202625.48 CNY
1/13/202625.76 CNY
1/12/202625.44 CNY
1/9/202625.51 CNY
1/8/202624.58 CNY
1/7/202624.60 CNY
1/6/202623.99 CNY
1/5/202624.30 CNY
12/31/202523.14 CNY
12/30/202523.09 CNY
12/29/202523.18 CNY
12/26/202523.59 CNY
12/25/202523.67 CNY
12/24/202523.90 CNY
12/23/202523.86 CNY
12/22/202523.16 CNY
12/19/202523.33 CNY
12/18/202523.02 CNY
12/17/202522.81 CNY
12/16/202522.83 CNY
12/15/202522.96 CNY
12/12/202523.79 CNY
12/11/202523.41 CNY
12/10/202523.70 CNY
12/9/202523.48 CNY
12/8/202523.75 CNY
12/5/202523.81 CNY
12/4/202523.76 CNY
12/3/202523.89 CNY
12/2/202524.28 CNY
12/1/202524.85 CNY
11/28/202525.12 CNY
11/27/202525.28 CNY
11/26/202525.25 CNY
11/25/202525.00 CNY
11/24/202525.09 CNY
11/21/202524.54 CNY
11/20/202525.39 CNY
11/19/202525.26 CNY
11/18/202526.06 CNY
11/17/202526.14 CNY
11/14/202526.69 CNY
11/13/202526.71 CNY
11/12/202526.29 CNY
11/11/202526.06 CNY
11/10/202526.10 CNY
11/7/202526.00 CNY
11/6/202526.42 CNY
11/5/202526.40 CNY
11/4/202526.54 CNY
11/3/202527.02 CNY
10/31/202527.58 CNY
10/30/202526.38 CNY
10/29/202526.70 CNY
10/28/202527.39 CNY
10/27/202527.25 CNY
10/24/202526.70 CNY
10/23/202526.64 CNY
10/22/202526.85 CNY
10/21/202527.05 CNY
10/20/202526.75 CNY
10/17/202526.55 CNY
10/16/202527.09 CNY
10/15/202527.00 CNY
10/14/202526.37 CNY
10/13/202527.18 CNY
10/10/202527.62 CNY
10/9/202528.21 CNY
9/30/202528.93 CNY
9/29/202528.99 CNY
9/26/202528.65 CNY
9/25/202529.41 CNY
9/24/202529.53 CNY
9/23/202529.02 CNY
9/22/202529.96 CNY
9/19/202529.70 CNY
9/18/202530.21 CNY
9/17/202530.76 CNY
9/16/202530.91 CNY
9/15/202531.27 CNY
9/12/202531.34 CNY
9/11/202531.02 CNY
9/10/202530.83 CNY
9/9/202530.96 CNY
9/8/202532.47 CNY
9/5/202533.23 CNY
9/4/202532.27 CNY
9/3/202533.97 CNY
9/2/202534.34 CNY
9/1/202534.72 CNY
8/29/202532.14 CNY
8/28/202530.97 CNY
8/27/202530.77 CNY
8/26/202532.01 CNY
8/25/202532.69 CNY
8/22/202532.94 CNY
8/21/202533.29 CNY
8/20/202534.44 CNY
8/19/202533.97 CNY
8/18/202533.98 CNY
8/15/202533.29 CNY
8/14/202532.35 CNY
8/13/202532.44 CNY
8/12/202531.01 CNY
8/11/202531.50 CNY
8/8/202530.45 CNY
8/7/202530.35 CNY
8/6/202531.23 CNY
Access this data via the Eulerpool API
Get Free API Key

Bio-Thera Solutions Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2019
700,000.00 CNY
-1.02 B CNY
-1.02 B CNY
Jan 1, 2020
185.00 M CNY
-524.90 M CNY
-513.20 M CNY
Jan 1, 2021
836.58 M CNY
96.44 M CNY
81.94 M CNY
Jan 1, 2022
455.13 M CNY
-494.66 M CNY
-480.40 M CNY
Jan 1, 2023
704.79 M CNY
-394.44 M CNY
-394.53 M CNY
Jan 1, 2024
743.17 M CNY
-496.81 M CNY
-510.30 M CNY
Jan 1, 2025 (e)
898.90 M CNY
-402.99 M CNY
-430.77 M CNY
Jan 1, 2026 (e)
1.08 B CNY
-249.47 M CNY
-284.39 M CNY

Bio-Thera Solutions Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 5, 2026, 4:07 PM
 
REVENUEB CNY
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM CNY
EBITB CNY
EBIT MARGIN%
NET INCOMEB CNY
NET INCOME GROWTH%
SHARESM
2016201720182019202020212022202320242025e2026e
––––0.190.840.460.700.740.901.08
–––––351.89-45.5754.735.5420.8620.49
25,650.0050.00––89.1995.6958.0272.4469.0469.0469.04
513.001.00513.00513.00165.00800.00264.00510.00513.00620.02747.06
-0.14-0.24-0.55-1.02-0.520.10-0.49-0.39-0.50-0.40-0.25
-7,100.00-11,950.00––-283.2411.48-108.57-55.97-66.76-44.77-23.01
-0.14-0.24-0.55-1.02-0.510.08-0.48-0.39-0.51-0.43-0.28
–72.79135.3284.81-49.80-115.79-692.59-17.9229.44-15.69-33.95
105.30105.30121.50345.50404.10414.08414.08414.08414.08414.08414.08
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Bio-Thera Solutions generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Bio-Thera Solutions retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Bio-Thera Solutions's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Bio-Thera Solutions has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Bio-Thera Solutions's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Bio-Thera Solutions stock margins

The Bio-Thera Solutions margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Bio-Thera Solutions. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Bio-Thera Solutions.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2019
85.71 %
-145,171.44 %
-146,085.72 %
Jan 1, 2020
89.24 %
-283.73 %
-277.41 %
Jan 1, 2021
95.71 %
11.53 %
9.79 %
Jan 1, 2022
58.01 %
-108.68 %
-105.55 %
Jan 1, 2023
72.38 %
-55.96 %
-55.98 %
Jan 1, 2024
69.09 %
-66.85 %
-68.67 %
Jan 1, 2025 (e)
69.09 %
-44.83 %
-47.92 %
Jan 1, 2026 (e)
69.09 %
-23.06 %
-26.28 %

Bio-Thera Solutions Stock Revenue, EBIT, Earnings per Share

The Bio-Thera Solutions earnings per share therefore indicates how much revenue Bio-Thera Solutions has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2019
0.00 CNY
-2.94 CNY
-2.96 CNY
Jan 1, 2020
0.46 CNY
-1.30 CNY
-1.27 CNY
Jan 1, 2021
2.02 CNY
0.23 CNY
0.20 CNY
Jan 1, 2022
1.10 CNY
-1.19 CNY
-1.16 CNY
Jan 1, 2023
1.70 CNY
-0.95 CNY
-0.95 CNY
Jan 1, 2024
1.79 CNY
-1.20 CNY
-1.23 CNY
Jan 1, 2025 (e)
2.17 CNY
-0.97 CNY
-1.04 CNY
Jan 1, 2026 (e)
2.61 CNY
-0.60 CNY
-0.69 CNY

Bio-Thera Solutions business model & stock analysis

Bio-Thera Solutions Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Bio-Thera Solutions historical P/E ratio, EBIT multiple, and P/S ratio

Bio-Thera Solutions annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Bio-Thera Solutions shares outstanding

The number of shares of Bio-Thera Solutions was 414.08 M in 2025. This indicates how many shares Bio-Thera Solutions is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2019
345.50 M Stocks
Jan 1, 2020
404.10 M Stocks
Jan 1, 2021
414.08 M Stocks
Jan 1, 2022
414.08 M Stocks
Jan 1, 2023
414.08 M Stocks
Jan 1, 2024
414.08 M Stocks
Jan 1, 2025 (e)
414.08 M Stocks
Jan 1, 2026 (e)
414.08 M Stocks

Current Bio-Thera Solutions forecasts and price targets in August 2026

Analyst Price Targets 2026
Δ MOM Price Target
0.00 %
Buy
80.00 % (4)
Hold
20.00 % (1)
Sell
0.00 % (0)
12M Price Target
36.92
Last Price
17.43
Currency
CNY
12M Return Potential
111.84 %
LTM Return
0 %

Bio-Thera Solutions shareholder structure

% Name
0.19555%
The Vanguard Group, Inc.
The Vanguard Group, Inc.
0.05866%
State Street Global Advisors (US)
State Street Global Advisors (US)
0.00052%
Vanguard Global Advisers LLC
Vanguard Global Advisers LLC
0.00051%
Vanguard Investments Australia Ltd.
Vanguard Investments Australia Ltd.

Bio-Thera Solutions Executives and Management Board

17 members · avg. age 53 · 24 % women

BI

Mr. Bert Thomas Iv (65)

Deputy General Manager

2.43 M CNY

Management

LM

Ms. Lan Mu (60)

Deputy General Manager

1.87 M CNY
WH

Ms. Wenrong Huang (53)

Deputy General Manager

1.60 M CNY
ZW

Mr. Zhaohe Wang (41)

Deputy General Manager

1.34 M CNY
JL

Mr. Jian Lin (43)

Deputy General Manager

1.17 M CNY
SS

Mr. Shuqiang Song (57)

Deputy General Manager

928,400.00 CNY
CB

Mr. Cai Bao (36)

Deputy General Manager

780,800.00 CNY

Board of Directors

JY

Mr. Jin-chen Yu (64)

Deputy General Manager, Director · since 2019

2.46 M CNY
SL

Mr. Shengfeng Li (63)

General Manager, Director · since 2019

2.01 M CNY
XH

Mr. Xianming Huang (57)

Director

1.89 M CNY
DY

Ms. Dan Yu (41)

Secretary of the Board, Director · since 2019

882,200.00 CNY
YJ

Mr. Yonghong Jiang (53)

Independent Director

120,000.00 CNY
QT

Mr. Qingquan Tang (62)

Independent Director

120,000.00 CNY

Bio-Thera Solutions Supply Chain

Bio-Thera Solutions Supply Chain

Correlation: how closely stock prices move together

Same directionNo relationOpposite
4 companies
#NameTrend
1
Cipla
Supplier·Customer·IN
-0.38
0.36
0.36
-0.46
-0.29
-0.82
2
Shanghai Medicilon A
Supplier·Life Sciences Tools & Services·CN
0.31
-0.09
0.46
0.58
0.77
-0.60
3
BeiGene
Supplier·Customer·CN
-0.60
0.55
0.76
0.85
0.81
-0.21
4
Biogen
Supplier·Customer·Biotechnology·US
0.48
0.77
0.41
0.70
0.55
0.16

Frequently asked questions about Bio-Thera Solutions

Analysts currently set an average price target of 36.92 CNY for the Bio-Thera Solutions stock (median: 36.92 CNY), implying +111.8 % versus the latest price. The consensus is based on 5 analyst ratings.

Bio-Thera Solutions Analyst Price Targets 2026

5 analysts currently rate the Bio-Thera Solutions stock: 4 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Bio-Thera Solutions to generate revenue of 1.08 B CNY and earnings per share of -0.69 CNY.

Bio-Thera Solutions Analyst Price Targets 2026

Converted at the current exchange rate, the Bio-Thera Solutions share trades at 2.32 EUR (18.10 CNY).

No history available for Bio-Thera Solutions.

The expected revenue of Bio-Thera Solutions is 1.08 B CNY. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Bio-Thera Solutions is -284.39 M CNY. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Bio-Thera Solutions is currently -26.35. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Bio-Thera Solutions stock.

The price-to-sales ratio (P/S) of Bio-Thera Solutions is currently 6.93. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Bio-Thera Solutions stock.

The Eulerpool Quality Score for Bio-Thera Solutions is 1/10.

The ISIN of Bio-Thera Solutions is CNE100003R98. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Bio-Thera Solutions is 688177.SS. The ticker symbol is used to trade Bio-Thera Solutions shares on the stock exchange.

Bio-Thera Solutions paid dividends every year for the past 0 years.

Bio-Thera Solutions is assigned to the 'Health' sector.

The dividends of Bio-Thera Solutions are distributed in CNY.

All fundamentals and in-depth analysis of Bio-Thera Solutions

Our stock analysis for Bio-Thera Solutions stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Bio-Thera Solutions. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Bio-Thera Solutions Stock
Bio-Thera Solutions Revenue→
Bio-Thera Solutions Stock
Bio-Thera Solutions Net Income→
Bio-Thera Solutions Stock
Bio-Thera Solutions P/E→
Bio-Thera Solutions Stock
Bio-Thera Solutions P/S→
Bio-Thera Solutions Stock
Bio-Thera Solutions EBIT→
Bio-Thera Solutions Stock
Bio-Thera Solutions Dividend→
Bio-Thera Solutions Stock
Bio-Thera Solutions Directors Dealings→
Bio-Thera Solutions Stock
Bio-Thera Solutions Stocks→
Bio-Thera Solutions Stock
Bio-Thera Solutions Market capitalization→
Bio-Thera Solutions Stock
Bio-Thera Solutions Debt→
Bio-Thera Solutions Stock
Bio-Thera Solutions Liabilities→
Bio-Thera Solutions Stock
Bio-Thera Solutions Equity→
Bio-Thera Solutions Stock
Bio-Thera Solutions AAQS→
Bio-Thera Solutions Stock
Bio-Thera Solutions Employees→
Bio-Thera Solutions Stock
Bio-Thera Solutions ROE→
Bio-Thera Solutions Stock
Bio-Thera Solutions ROA→
Bio-Thera Solutions Stock
Bio-Thera Solutions ROCE→
Bio-Thera Solutions Stock
Bio-Thera Solutions News→
Bio-Thera Solutions Stock
Bio-Thera Solutions Analyst Price Targets→

Health Stocks

Bio-Works TechnologiesBio-TechnebioAffinity TechnologiesBio-FD&C CoBIOAGE LabsBio ViewBioArcticBio Solution CoBioatlaBio Rad LaboratoriesBiobijou CoBio Preventive MedicineAll Stocks A–Z →